D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Psychology D-index 102 Citations 36,853 493 World Ranking 300 National Ranking 44
Medicine D-index 111 Citations 46,013 744 World Ranking 2284 National Ranking 225

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Law

David J. Nutt mainly focuses on Psychiatry, Neuroscience, Anxiety, Pharmacology and Clinical psychology. His Psychiatry study frequently draws connections to other fields, such as Evidence-based practice. As a part of the same scientific study, David J. Nutt usually deals with the Neuroscience, concentrating on Psychedelic experience and frequently concerns with Psychedelic therapy, Functional magnetic resonance imaging, Default mode network and Resting state fMRI.

His work in Pharmacology tackles topics such as Benzodiazepine which are related to areas like GABAA receptor and Antagonist. His Panic disorder study also includes fields such as

  • Panic which connect with Flumazenil,
  • Serotonin, which have a strong connection to Neurotransmitter. His studies deal with areas such as Cognition and MEDLINE as well as Depression.

His most cited work include:

  • Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. (1044 citations)
  • Drug harms in the UK: a multicriteria decision analysis. (907 citations)
  • Development of a rational scale to assess the harm of drugs of potential misuse (821 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Psychiatry, Pharmacology, Internal medicine, Anxiety and Endocrinology. Psychiatry is closely attributed to Clinical psychology in his study. His Pharmacology research incorporates elements of Agonist, Receptor and Benzodiazepine.

He does research in Internal medicine, focusing on Serotonin specifically. His study involves Anxiety disorder, Panic disorder and Generalized anxiety disorder, a branch of Anxiety. David J. Nutt interconnects Antagonist and Idazoxan in the investigation of issues within Endocrinology.

He most often published in these fields:

  • Psychiatry (29.99%)
  • Pharmacology (17.15%)
  • Internal medicine (16.90%)

What were the highlights of his more recent work (between 2013-2021)?

  • Psychiatry (29.99%)
  • Neuroscience (13.09%)
  • Addiction (8.53%)

In recent papers he was focusing on the following fields of study:

David J. Nutt spends much of his time researching Psychiatry, Neuroscience, Addiction, Clinical psychology and Pharmacology. Psychiatry is closely attributed to MEDLINE in his research. Many of his studies involve connections with topics such as Receptor and Neuroscience.

His Addiction research incorporates themes from Alcohol dependence, Endocrinology, Psychotherapist, Internal medicine and Criminology. His studies link Anxiety with Clinical psychology. His research in Psilocybin is mostly concerned with Psychedelic therapy.

Between 2013 and 2021, his most popular works were:

  • Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (402 citations)
  • The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (356 citations)
  • The dopamine theory of addiction: 40 years of highs and lows (335 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Law

David J. Nutt mainly investigates Psychiatry, Neuroscience, Clinical psychology, Addiction and Psilocybin. His Psychiatry research includes themes of Alternative medicine and Internal medicine. David J. Nutt focuses mostly in the field of Clinical psychology, narrowing it down to matters related to Anxiety and, in some cases, Biomarker and Neuroimaging.

His biological study spans a wide range of topics, including Alcohol, Alcohol dependence, Impulsivity, Dopamine and Opioid. His Psilocybin research integrates issues from Psychotherapist, Treatment-resistant depression and Mood. His Endogenous opioid research is multidisciplinary, relying on both Endocrinology and Pharmacology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Drug harms in the UK: a multicriteria decision analysis.

David J Nutt;Leslie A King;Lawrence D Phillips.
The Lancet (2010)

1664 Citations

Development of a rational scale to assess the harm of drugs of potential misuse

David Nutt;Leslie A King;William Saulsbury;Colin Blakemore.
The Lancet (2007)

1432 Citations

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.

Vassilios Papadopoulos;Mario Baraldi;Tomás R. Guilarte;Thomas B. Knudsen.
Trends in Pharmacological Sciences (2006)

1322 Citations

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Robin L. Carhart-Harris;David Erritzoe;Tim Williams;James M. Stone.
Proceedings of the National Academy of Sciences of the United States of America (2012)

745 Citations

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

David S. Baldwin;Ian M. Anderson;David J. Nutt;Borwin Bandelow.
Journal of Psychopharmacology (2005)

715 Citations

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin L. Carhart-Harris;Mark Bolstridge;James Rucker;Camilla M. J. Day.
The Lancet Psychiatry (2016)

627 Citations

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Robin Lester Carhart-Harris;Robert Leech;Peter John Hellyer;Murray Shanahan.
Frontiers in Human Neuroscience (2014)

573 Citations

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

S. J. Wilson;D. J. Nutt;C. Alford;S. V. Argyropoulos.
Journal of Psychopharmacology (2010)

537 Citations

Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety

James C. Ballenger;Jonathan R. T. Davidson;Yves Lecrubier;David J. Nutt.
The Journal of Clinical Psychiatry (2000)

521 Citations

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines:

I. M. Anderson;D. J. Nutt;J. F. W. Deakin.
Journal of Psychopharmacology (2000)

511 Citations

Editorial Boards

Journal of Psychopharmacology
(Impact Factor: 4.562)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David J. Nutt

Dan J. Stein

Dan J. Stein

University of Cape Town

Publications: 135

David S. Baldwin

David S. Baldwin

University of Southampton

Publications: 116

Vassilios Papadopoulos

Vassilios Papadopoulos

University of Southern California

Publications: 111

Siegfried Kasper

Siegfried Kasper

Medical University of Vienna

Publications: 111

Jürgen Rehm

Jürgen Rehm

Centre for Addiction and Mental Health

Publications: 96

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 80

Trevor W. Robbins

Trevor W. Robbins

University of Cambridge

Publications: 78

John H. Krystal

John H. Krystal

Yale University

Publications: 71

Alessandro Serretti

Alessandro Serretti

University of Bologna

Publications: 67

John F. Cryan

John F. Cryan

University College Cork

Publications: 65

Robin L. Carhart-Harris

Robin L. Carhart-Harris

Imperial College London

Publications: 61

Morten L. Kringelbach

Morten L. Kringelbach

University of Oxford

Publications: 58

Philip J. Cowen

Philip J. Cowen

University of Oxford

Publications: 57

Glyn Lewis

Glyn Lewis

University College London

Publications: 56

Sandra E. File

Sandra E. File

University of London

Publications: 55

Christer Halldin

Christer Halldin

Stockholm County Council

Publications: 55

Trending Scientists

Roger M. Goodall

Roger M. Goodall

Loughborough University

Chun-Ming Chang

Chun-Ming Chang

Chung Yuan Christian University

Johan C. Kraak

Johan C. Kraak

University of Amsterdam

Geoff A. Parker

Geoff A. Parker

University of Liverpool

Wei Shou Hu

Wei Shou Hu

University of Minnesota

Michael Simons

Michael Simons

Yale University

Henryk Czosnek

Henryk Czosnek

Hebrew University of Jerusalem

Anne de Vernal

Anne de Vernal

University of Quebec at Montreal

Allan R. Robinson

Allan R. Robinson

Harvard University

Antonio D. Nobre

Antonio D. Nobre

National Institute for Space Research

Mikael Ehn

Mikael Ehn

University of Helsinki

Robyn E O'Hehir

Robyn E O'Hehir

Monash University

Daniel C. Molden

Daniel C. Molden

Northwestern University

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Alan N. Barkun

Alan N. Barkun

McGill University Health Centre

Kathleen Daly

Kathleen Daly

Griffith University

Something went wrong. Please try again later.